PeriphaGen (Formerly Diamyd) is Biotechnology in United States that focus on manage pain business. Founded in 2003. They cover business area such as operator, gene delivery product, pain and peripheral nerve damage, its pipeline, chronic pain, NET drug, multiple pain pathway, various gene combination.
2003
( 21 years old in 2024 )
Manage Pain
-
2100 Wharton Street
Suite 701
Pittsburgh, PA 15203
United States
Private
operatorgene delivery productpain and peripheral nerve damageits pipelinechronic painNET drugmultiple pain pathwayvarious gene combination
* We use standard office opening hours in near PeriphaGen (Formerly Diamyd)'s location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
PeriphaGen (Formerly Diamyd) is Biotechnology business from United States that founded in 2003 (21 years old in 2024), PeriphaGen (Formerly Diamyd) business is focusing on Manage Pain.
PeriphaGen (Formerly Diamyd) headquarter office and corporate office address is located in 2100 Wharton Street Suite 701 Pittsburgh, PA 15203 United States.
PeriphaGen (Formerly Diamyd) was founded in United States.
In 2024, PeriphaGen (Formerly Diamyd) is currently focus on manage pain sector.
Above is snippet of Google Trends for "manage pain" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with PeriphaGen (Formerly Diamyd), any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
